Technology | August 13, 2007

New Computerized Test Identifies More Cervical Cancers than Conventional Pap Smear

A new computerized test called the ThinPrep Imager detects more high-grade cervical cancers than a conventional Pap smear, Australian researchers report.
The advantage of this new test is that it could lead to fewer women being retested based on inconclusive Pap smear findings, and allow for a longer time between screenings, the researchers said.
“In the samples read by the ThinPrep Imager, there was a significant 17 percent increased detection of high-grade lesions,” said researcher Dr. Annabelle Farnsworth, medical director of the Cytology Department at Douglass Hanly Moir Pathology, in North Ryde. “There was also a 50 percent decrease in unsatisfactory slides,” she added.
The study was funded by the Australian National Health and Medical Research Council.
In the study, Farnsworth’s team used the computerized ThinPrep Imager reading system to evaluate liquid-based cytology slides. The imager is designed to highlight any slides that need further examination. These slides were then examined by a cytologist.
The researchers found that in samples from 55,164 Australian women, the ThinPrep Imager found 1.3 more cases of high-grade cervical abnormalities per 1,000 women screened than the conventional Pap test.

Related Content

Hologic, ECR 2017, breast cancer screening solutions, Affirm prone biopsy system

The Affirm prone biopsy system. Image courtesy of Hologic.

News | Breast Imaging | March 14, 2017
Hologic Inc. highlighted its portfolio of innovative breast cancer screening and interventional products, including new...
Sponsored Content | Videos | Women's Health | November 16, 2016
The purpose of this exploratory video roundtable is to examine the state of breast biopsies today and to communicate...
stereotactic breast imaging

This image shows a 52-year-old patient with benign calcifications in her pre-stereotactic breast biopsy screening.

Feature | Breast Biopsy Systems | November 01, 2016 | By Laura Shepardson, M.D.
Recently, I was invited to participate in a...
Hologic, FDA approval, launch, Affirm prone biopsy system, breast cancer, women's health
Technology | Breast Biopsy Systems | April 21, 2016
Hologic Inc. announced the U.S. Food and Drug Administration (FDA) clearance and commercial launch of the Affirm prone...

Breast surgeon Michael Cross, M.D., has done clinical research on the DotMed BioZorb surgical marker. (Photo courtesy of DotMed)

Feature | Women's Health | November 11, 2015
Breast cancer research conducted by two Fayetteville, Ark., medical groups highlights their success in pioneering use
Hologic, RSNA 2015, breast tomosynthesis, breast biopsy systems

I-View contrast enhanced 2-D mammography image courtesy of Hologic

Technology | Breast Imaging | October 02, 2015
October 2, 2015 — At the Radiological Society of North America’s (RSNA) 2015 annual meeting, Hologic will emphasize i
hologic mammography Selin
News | Breast Imaging | October 01, 2015
October 1, 2015 — The recent KLAS Research women’s imaging report, Women's Imaging 2015.
Cianna Medical, SAVI Scout, breast surgical guidance system

Photo courtesy of Cianna Medical

Technology | December 16, 2014
Cianna Medical Inc. received U.S. Food and Drug Administration (FDA) clearance for the SAVI Scout surgical guidance...
News | November 12, 2014
GTCR, a private equity firm, announced Devicor Medical Products has signed an agreement to be acquired by Danaher Corp...
News | November 11, 2014
Seno Medical Instruments Inc. announced that the use of the Seno Imagio breast imaging system and the associated...
Overlay Init